News
Inventors at the NIH National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) are seeking a licensee or collaborator for positive allosteric modulators (PAMs) of the A 3 adenosine receptor (A 3AR), a known therapeutic target. These heterocyclic chemical compounds bind to a lipid
In a recently released report, the NIH details its plans for Accelerating Technology Transfer and Commercialization in Support of High Growth Business. The Plan is a response to the October 28, 2011 Presidential Memorandum ( http://1.usa.gov/uHoAA4) that required federal agencies to streamline
Researchers have launched a clinical trial at the NIH Clinical Center to evaluate the drug candidate DEX-M74 as a treatment for a rare degenerative muscle disease, hereditary inclusion body myopathy (HIBM). DEX-M74, based on an NIH technology, is being developed through a collaboration between the
The NIH Office of Technology Transfer, Johns Hopkins University Technology Transfer and TTS Ltd., are pleased to announce that the 2012 edition of the Tech Transfer Summit North America (TTSNA) will take place on October 22-23, 2012. The conference will take place at at the Montgomery County